Werewolf Therapeutics Inc (HOWL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $47.64M
Last updated: Nov 17, 2026 at 11:05 AM ET
Werewolf Therapeutics Inc (HOWL) Earnings: Report Dates and Results
Werewolf Therapeutics (HOWL) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Werewolf Therapeutics reported EPS of -$0.20, above the -$0.22 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
HOWL has an expected report date of Mar 22, 2027.
Earnings History
Of the 21 quarters below that had an estimate, HOWL beat 16 and missed 5. The widest gap in the table came in the quarter ended Jun 30, 2026, when EPS landed 128.57% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.20 | -$0.22 | -$0.22 - -$0.22 | +9.09% | Beat | N/A | 1 | 1 up, 0 down | Nov 13, 2026 | N/A |
| Jun 30, 2026 | $0.08 | -$0.28 | N/A | +128.57% | Beat | N/A | 1 | 1 up, 0 down | Jul 31, 2026 | $21.00M |
| Mar 31, 2026 | -$0.28 | -$0.30 | -$0.32 - -$0.27 | +5.08% | Beat | N/A | 2 | 1 up, 0 down | May 7, 2026 | N/A |
| Dec 31, 2025 | -$0.17 | -$0.35 | -$0.37 - -$0.27 | +51.43% | Beat | N/A | 3 | 1 up, 0 down | Mar 27, 2026 | N/A |
| Sep 30, 2025 | -$0.36 | -$0.38 | -$0.41 - -$0.36 | +5.26% | Beat | N/A | 4 | 2 up, 0 down | Nov 4, 2025 | N/A |
| Jun 30, 2025 | -$0.40 | -$0.37 | -$0.39 - -$0.36 | -8.11% | Miss | N/A | 3 | 2 up, 0 down | Aug 14, 2025 | N/A |
| Mar 31, 2025 | -$0.40 | -$0.43 | -$0.45 - -$0.42 | +6.98% | Beat | N/A | 3 | 0 up, 1 down | May 8, 2025 | N/A |
| Dec 31, 2024 | -$0.46 | -$0.42 | N/A | -9.52% | Miss | N/A | 3 | 3 up, 0 down | Mar 11, 2025 | N/A |
| Sep 30, 2024 | -$0.38 | -$0.39 | -$0.45 - -$0.36 | +2.56% | Beat | N/A | 6 | 0 up, 0 down | Nov 7, 2024 | N/A |
| Jun 30, 2024 | -$0.38 | -$0.39 | -$0.43 - -$0.29 | +2.56% | Beat | N/A | 5 | 0 up, 0 down | Aug 8, 2024 | $1.14M |
| Mar 31, 2024 | -$0.39 | -$0.34 | -$0.41 - -$0.28 | -14.71% | Miss | N/A | 5 | 0 up, 0 down | May 3, 2024 | $742000 |
| Dec 31, 2023 | -$0.33 | -$0.43 | -$0.53 - -$0.29 | +23.26% | Beat | N/A | 5 | 0 up, 0 down | Mar 7, 2024 | $1.50M |
| Sep 30, 2023 | -$0.23 | -$0.34 | -$0.45 - -$0.27 | +32.35% | Beat | N/A | 5 | 0 up, 0 down | Nov 14, 2023 | $5.90M |
| Jun 30, 2023 | -$0.14 | -$0.40 | -$0.48 - -$0.34 | +65.00% | Beat | N/A | 5 | 0 up, 0 down | Aug 10, 2023 | $8.08M |
| Mar 31, 2023 | -$0.34 | -$0.46 | -$0.59 - -$0.43 | +26.09% | Beat | N/A | 4 | 0 up, 0 down | May 11, 2023 | $4.46M |
| Dec 31, 2022 | -$0.39 | -$0.55 | -$0.76 - -$0.38 | +29.09% | Beat | N/A | 5 | 0 up, 0 down | Mar 23, 2023 | $7.28M |
| Sep 30, 2022 | -$0.40 | -$0.56 | -$0.81 - -$0.19 | +28.57% | Beat | N/A | 4 | 1 up, 0 down | Nov 10, 2022 | $4.97M |
| Jun 30, 2022 | -$0.53 | -$0.60 | -$0.62 - -$0.07 | +11.67% | Beat | N/A | 4 | 0 up, 0 down | Aug 11, 2022 | $4.15M |
| Mar 31, 2022 | -$0.56 | -$0.58 | -$0.70 - -$0.45 | +3.45% | Beat | N/A | 4 | 0 up, 0 down | May 10, 2022 | N/A |
| Dec 31, 2021 | -$0.66 | -$0.53 | -$0.56 - -$0.50 | -24.53% | Miss | N/A | 4 | N/A | Mar 24, 2022 | N/A |
| Sep 30, 2021 | -$0.51 | -$0.46 | -$0.54 - -$0.36 | -10.87% | Miss | N/A | 4 | N/A | Nov 10, 2021 | N/A |
| Jun 30, 2021 | -$3.82 | -$0.28 | -$0.55 - -$0.27 | N/A | N/A | N/A | 3 | N/A | Aug 12, 2021 | N/A |
| Mar 31, 2021 | -$83.36 | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | Apr 30, 2021 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.33, after -$1.61 the year before. It was -$88.35 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.33 | N/A |
| Dec 31, 2024 | -$1.61 | N/A |
| Dec 31, 2023 | -$1.04 | N/A |
| Dec 31, 2022 | -$1.88 | N/A |
| Dec 31, 2021 | -$88.35 | N/A |
Frequently Asked Questions About HOWL
When is Werewolf Therapeutics's next earnings date?
Werewolf Therapeutics's next earnings report is expected for Mar 22, 2027.
Did HOWL beat earnings estimates last quarter?
Yes. Werewolf Therapeutics reported EPS of -$0.20 for the quarter ended Sep 30, 2026, above the -$0.22 estimate, a 9.09% surprise.
What EPS do analysts expect from HOWL next quarter?
The consensus EPS estimate for Werewolf Therapeutics for the quarter ending Dec 31, 2026 is -$0.17 from 3 analysts.
How often does HOWL beat earnings estimates?
Werewolf Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +23.60%.
HOWL pages: Overview, Earnings, Forecast, Financials, Competitors